Heartflow HTFL
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$800.7K (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 39.9% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 7.80% to 6.54% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +843,196 | 6.9% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +727,316 | 0.8% |
| FMR | Mutual Fund | 2026/Q3 | +668,876 | 6.3% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +611,200 | 1.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +562,484 | 3.8% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +456,994 | 2.1% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +394,190 | 0.5% |
| Morgan Stanley | Public Company | 2026/Q3 | +374,208 | 1.6% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +374,208 | 1.6% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +567,213 | 0.7% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +1,368,603 | 10.6% |
| Catalio Capital Management, LP | VC/PE Fund | 2026/Q3 | +1,792,640 | 2.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,735,163 | 6.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,538,490 | 4.1% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,182,928 | 2.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | John Farquhar | Chief Executive Officer | Automatic Disposition | -23,280 | $55.74 | 251,983 |
| 9 Nov 2026 | John Farquhar | Chief Executive Officer | Derivative Exercise and Sale | -15,620 | $55.74 | 251,983 |
| 8 Nov 2026 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -3,587 | $53.15 | 79,463 |
| 5 Nov 2026 | Campbell Rogers | Chief Medical Officer & Executive VP | Sale to Issuer | -2,270 | $52.40 | 158,315 |
| 5 Nov 2026 | Mhairi Jones | Sale to Issuer | -568 | $52.40 | 12,116 | |
| 5 Nov 2026 | John Farquhar | Chief Executive Officer | Sale to Issuer | -7,751 | $52.40 | 251,983 |
| 5 Nov 2026 | Vikram Verghese | Chief Financial Officer | Sale to Issuer | -2,009 | $52.40 | 79,463 |
| 21 Oct 2026 | Campbell Rogers | Chief Medical Officer & Executive VP | Open Market Disposition | -6,503 | $55.01 | 155,890 |
| 21 Oct 2026 | Campbell Rogers | Chief Medical Officer & Executive VP | Derivative Exercise and Sale | -17,430 | $55.01 | 155,890 |
| 11 Oct 2026 | John Farquhar | Chief Executive Officer | Automatic Disposition | -38,900 | $49.57 | 283,014 |
| 17 Sep 2026 | Campbell Rogers | Chief Medical Officer & Executive VP | Automatic Disposition | -6,503 | $50.15 | 162,393 |
| 17 Sep 2026 | Campbell Rogers | Chief Medical Officer & Executive VP | Derivative Exercise and Sale | -13,179 | $50.15 | 162,393 |
| 17 Sep 2026 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -16,766 | $50.75 | – |
| 17 Sep 2026 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -24,345 | $50.75 | 79,463 |
| 16 Sep 2026 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -7,579 | $50.11 | – |
| 14 Sep 2026 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -668 | $50.01 | – |
| 14 Sep 2026 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -34,975 | $50.24 | 103,808 |
| 13 Sep 2026 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -4,593 | $50.24 | – |
| 10 Sep 2026 | John Farquhar | Chief Executive Officer | Intent to Sell (Form 144) | -3,890 | $50.00 | – |
| 10 Sep 2026 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -29,714 | $50.06 | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 5,688,103 | 6.5% | 3.5 |
| 15 Oct 2026 | 7,327,567 | 8.4% | 4.4 |
| 30 Sep 2026 | 6,813,775 | 7.8% | 3.3 |
| 15 Sep 2026 | 5,627,391 | 6.5% | 3.1 |
| 31 Aug 2026 | 6,068,706 | 7.0% | 2.5 |
| 14 Aug 2026 | 6,779,888 | 7.8% | 3.9 |
No comments yet — be the first to weigh in on HTFL.
Sign in to join the discussion.